RecallRadar

FDA Drug recall D-0249-2025

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08…

On 2025-03-12 the FDA classified a Class II recall of Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08… by Sun Pharmaceutical Industries, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0249-2025
ClassificationClass II
Statusongoing
Initiated2025-02-06
Published2025-03-12
Last updated2026-09-13 11:52 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01

Reason

Failed Dissolution Specifications

Identifiers

ndc63304-450-03
ndc63304-450-01
ndc63304-450-05
ndc63304-451-03
ndc63304-451-01
ndc63304-451-05
ndc63304-758-03
ndc63304-758-01
ndc63304-758-05
ndc63304-758-50
ndc63304-452-03
ndc63304-452-01
ndc63304-452-05
ndc63304-453-03
ndc63304-453-01
ndc63304-453-05
code_infoLot #: AD16615, Exp. Date 07/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0249-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.